Most research on pregestational diabetes has focused on type 1 diabetes, and surprisingly little knowledge exists concerning outcomes of pregnancies of women with type 2 diabetes. A dearth of published data suggest outcomes similar to those of type 1 diabetic women (1,2), although recent studies report poorer outcomes in women with type 2 diabetes (37).

We retrospectively compared maternal and perinatal outcomes of 93 consecutive singleton pregnancies in women with type 2 diabetes and 532 consecutive singleton pregnancies in women with type 1 diabetes referred to the Diabetes and Pregnancy Unit at University Hospital La Paz from 1984 to 2004.

Women with type 2 diabetes were significantly older ([means ± SD] 31.8 ± 5.5 vs. 29.4 ± 4.7 years, P < 0.001), were more frequently obese (45.2 vs. 9%, P < 0.001), and had a shorter duration of diabetes (5.7 ± 6 vs. 11.8 ± 7.1 years, P < 0.001). The rate of preconceptional care (16.1 vs. 22.6%, P = 0.175) and gestational age at first visit (12.1 ± 6.8 vs. 11.5 ± 6.9 weeks’ gestation, P = 0.529) did not differ between type 2 and type 1 diabetic women. Maternal and perinatal outcomes are shown in Table 1. Insulin requirements and HbA1c (A1C) were lower during all three trimesters of pregnancy in type 2 diabetic women. Maternal weight gain and the rate of caesarean deliveries were lower in type 2 diabetes. Gestational age at birth was significantly higher and the rate of large infants for gestational age lower in infants of women with type 2 diabetes. The rates of perinatal mortality and major congenital malformations were comparable in both groups. First-trimester A1C in type 2 and type 1 diabetic mothers with perinatal mortality was 9.9 and 8.1 ± 1.2%, respectively. Among pregnancies complicated by major congenital malformations, first-trimester A1C was >7% in 84% of women with type 1 diabetes and only in one woman (16.7%) with type 2 diabetes (P = 0.006). Neonatal distress respiratory syndrome was more frequent in infants of mothers with type 1 diabetes.

In our study, pregnancy outcomes in type 2 diabetic women were, if anything, similar to those with type 1 diabetes. In fact, women with type 2 diabetes had lower rates of large infants for gestational age, neonatal respiratory distress syndrome, and caesarean delivery.

As in some of the studies available, we found no significant differences in perinatal mortality or major congenital malformations between women with type 2 and type 1 diabetes (12). However, the results of five recent publications (37) suggest that type 2 diabetes could even represent a higher risk of perinatal mortality or congenital malformations than that conferred by type 1 diabetes. Similar rates of preconceptional care in women with type 1 and type 2 diabetes in our study could explain this discrepancy, as could the fact that gestational age at first visit to the clinic was comparable in both type 1 and type 2 diabetic women who did not undergo preconceptional care.

In our study, congenital malformations in type 2 diabetes were not related to poor first-trimester metabolic control in most cases. The concurrence in women with type 2 diabetes of factors other than glycemic control, such as obesity and older age, may account for this finding (8).

In conclusion, our study shows that pregnancy outcomes in type 2 diabetes are better than in type 1 diabetes when type 2 diabetic women receive as much intensified medical treatment during preconception and pregnancy as that given to type 1 diabetic women.

Table 1—

Maternal and perinatal outcomes

Type 2 diabetesType 1 diabetesP
n* 93 532  
Prepregnancy BMI (kg/m228.9 ± 6.5 23.3 ± 3.1 <0.001 
Maternal weight gain during pregnancy (kg) 11.7 ± 5.0 13.7 ± 4.2 <0.001 
Glycemic control during pregnancy    
    A1C at admission (%) 6.4 ± 1.19 7.2 ± 1.19 <0.001 
    A1C second trimester (%) 5.8 ± 0.84 6.3 ± 0.9 <0.001 
    A1C third trimester (%) 5.8 ± 0.76 6.2 ± 0.8 0.001 
Insulin requirements    
    First trimester (units/kg) 0.38 ± 0.19 0.68 ± 0.18 <0.001 
    Second trimester (units/kg) 0.48 ± 0.23 0.76 ± 0.21 <0.001 
    Third trimester (units/kg) 0.62 ± 0.31 0.93 ± 0.26 <0.001 
Pregnancy-induced hypertension 18 (19.4) 82 (15.4) 0.358 
Preeclampsia 6 (6.5) 17 (3.2) 0.134 
Caesarean delivery 41 (44.1) 298 (56) 0.032 
Gestational age (weeks of     gestation) 37.1 ± 1.6 36.7 ± 1.7 0.018 
Preterm delivery 28 (30.4) 186 (35.4) 0.406 
Birth weight (g) 3,182 ± 623 3,243 ± 606 0.375 
Birth weight ratio 1.09 ± 0.2 1.13 ± 0.18 0.019 
Large for gestational age 22 (23.9) 187 (35.6) 0.032 
Small for gestational age 3 (3.3) 5 (1) 0.100 
Perinatal mortality 1 (1.1) 9 (1.7) 1.000 
Major congenital malformations 6 (6.5) 25 (4.7) 0.442 
Neonatal hypoglycemia 24 (26.1) 172 (32.8) 0.226 
Neonatal hyperbilirrubinemia 34 (37) 223 (42.5) 0.359 
Neonatal hypocalcemia 4 (4.3) 30 (5.7) 0.805 
Birth trauma 7 (7.6) 29 (5.5) 0.467 
Neonatal sepsis 9 (9.8) 55 (10.5) 1.000 
Neonatal polycythemia 14 (15.2) 71 (13.5) 0.626 
Neonatal respiratory distress syndrome 7 (7.6) 95 (18.1) 0.010 
Type 2 diabetesType 1 diabetesP
n* 93 532  
Prepregnancy BMI (kg/m228.9 ± 6.5 23.3 ± 3.1 <0.001 
Maternal weight gain during pregnancy (kg) 11.7 ± 5.0 13.7 ± 4.2 <0.001 
Glycemic control during pregnancy    
    A1C at admission (%) 6.4 ± 1.19 7.2 ± 1.19 <0.001 
    A1C second trimester (%) 5.8 ± 0.84 6.3 ± 0.9 <0.001 
    A1C third trimester (%) 5.8 ± 0.76 6.2 ± 0.8 0.001 
Insulin requirements    
    First trimester (units/kg) 0.38 ± 0.19 0.68 ± 0.18 <0.001 
    Second trimester (units/kg) 0.48 ± 0.23 0.76 ± 0.21 <0.001 
    Third trimester (units/kg) 0.62 ± 0.31 0.93 ± 0.26 <0.001 
Pregnancy-induced hypertension 18 (19.4) 82 (15.4) 0.358 
Preeclampsia 6 (6.5) 17 (3.2) 0.134 
Caesarean delivery 41 (44.1) 298 (56) 0.032 
Gestational age (weeks of     gestation) 37.1 ± 1.6 36.7 ± 1.7 0.018 
Preterm delivery 28 (30.4) 186 (35.4) 0.406 
Birth weight (g) 3,182 ± 623 3,243 ± 606 0.375 
Birth weight ratio 1.09 ± 0.2 1.13 ± 0.18 0.019 
Large for gestational age 22 (23.9) 187 (35.6) 0.032 
Small for gestational age 3 (3.3) 5 (1) 0.100 
Perinatal mortality 1 (1.1) 9 (1.7) 1.000 
Major congenital malformations 6 (6.5) 25 (4.7) 0.442 
Neonatal hypoglycemia 24 (26.1) 172 (32.8) 0.226 
Neonatal hyperbilirrubinemia 34 (37) 223 (42.5) 0.359 
Neonatal hypocalcemia 4 (4.3) 30 (5.7) 0.805 
Birth trauma 7 (7.6) 29 (5.5) 0.467 
Neonatal sepsis 9 (9.8) 55 (10.5) 1.000 
Neonatal polycythemia 14 (15.2) 71 (13.5) 0.626 
Neonatal respiratory distress syndrome 7 (7.6) 95 (18.1) 0.010 

Data are means ± SD or n (%) unless otherwise indicated.

*

In the case of stillbirths (one in type 2 and seven in type 1 diabetes), no perinatal data other than the presence of major congenital malformations was analyzed;

adjusted for multiplicity.

1
Feig DS, Palda VA: Type 2 diabetes in pregnancy: a growing concern.
Lancet
359
:
1690
–1692,
2002
2
Diabetes and Pregnancy Group, France: French multicentric survey of outcome of pregnancy in women with pregestational diabetes.
Diabetes Care
26
:
2990
–2993,
2003
3
Omori Y, Minei S, Testuo T, Nemoto K, Shimizu M, Sanaka M: Current status of pregnancy in diabetic women: a comparison of pregnancy in IDDM and NIDDM mothers.
Diabetes Res Clin Pract
24 (Suppl.)
:
S273
–S278, 1994
4
Brydon P, Smith T, Proffitt M, Gee H, Holder R, Dunne F: Pregnancy outcome in women with type 2 diabetes mellitus needs to be addressed.
Int J Clin Pract
54
:
418
–419,
2000
5
Cundy T, Gamble G, Townend K, Henley PG, MacPherson P, Roberts AB: Perinatal mortality in type 2 diabetes mellitus.
Diabet Med
17
:
33
–39,
2000
6
Clausen TD, Mathiesen E, Ekbom P, Hellmuth E, Mandrup-Poulsen T, Damm P: Poor pregnancy outcome in women with type 2 diabetes.
Diabetes Care
28
:
323
–328,
2005
7
Roland JM, Murphy HR, Ball V, Northcote-Wright J, Temple RC: The pregnancies of women with type 2 diabetes: poor outcomes but opportunities for improvement.
Diabet Med
22
:
1774
–1777,
2005
8
Garcia-Patterson A, Erdozain L, Ginovart G, Adelantado JM, Cubero JM, Gallo G, de Leiva A, Corcoy R: In human gestational diabetes mellitus congenital malformations are related to pre-pregnancy body mass index and to severity of diabetes.
Diabetologia
47
:
509
–514,
2004